Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M336Revenue $M34.7Net Margin (%)-55.3Z-Score-35.8
Enterprise Value $M317EPS $-0.4Operating Margin %-48.6F-Score6
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-56.3Higher ROA y-yY
Price/Book18.410-y EBITDA Growth Rate %-43.4Quick Ratio1.8Cash flow > EarningsY
Price/Sales4.35-y EBITDA Growth Rate %-58.4Current Ratio1.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-61.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-204.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M150ROI % (ttm)-75.7Gross Margin Increase y-yY

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CTIC is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SINGER JACK WEVP Global Medical Affairs 2015-02-27Sell15,000$2.35-0.43view
BIANCO LOUIS AEVP, Finance & Administration 2015-02-05Sell10,000$2.225.41view
Plunkett MatthewEVP, Corporate Development 2015-02-04Sell12,000$2.225.41view
BIANCO LOUIS AEVP, Finance & Administration 2015-01-08Sell10,000$2.320.86view
Plunkett MatthewEVP, Corporate Development 2015-01-05Sell12,000$2.36-0.85view
BIANCO JAMES APresident and CEO 2014-12-19Sell40,000$2.44-4.1view
BIANCO LOUIS AEVP, Finance & Administration 2014-12-04Sell10,000$2.254view
Plunkett MatthewEVP, Corporate Development 2014-12-04Sell12,000$2.234.93view
BIANCO LOUIS AEVP, Finance & Administration 2014-11-06Sell10,000$2.37-1.27view
Plunkett MatthewEVP, Corporate Development 2014-11-04Sell12,000$2.39-2.09view

Press Releases about CTIC :

    Quarterly/Annual Reports about CTIC:

    News about ctic:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
    comment on CTIC Dec 16 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
    Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 200,000 Shares Dec 17 2010 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 150,000 Shares Dec 10 2010 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 100,000 Shares Nov 05 2010 


    More From Other Websites
    CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Feb 26 2015
    CTI BioPharma to Report Fourth Quarter and Full Year 2014 Financial Results on March 12, 2015 Feb 26 2015
    CTI BioPharma to Report Fourth Quarter and Full Year 2014 Financial Results on March 12, 2015 Feb 26 2015
    CTI BioPharma (CTIC) Rises: Stock Adds 5.3% in Session - Tale of the Tape Feb 24 2015
    CTI BioPharma Announces Independent DMC Recommendation to Continue GOG-0212 Phase 3 Study of... Feb 03 2015
    Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule? Jan 30 2015
    CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jan 29 2015
    Tuesday Morning Movers: ChannelAdvisor Plummets Jan 13 2015
    US STOCKS-Futures higher after 2-day decline, Alcoa results Jan 13 2015
    US STOCKS-Futures higher after 2-day decline, Alcoa results Jan 13 2015
    CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jan 13 2015
    CTI BioPharma Appoints Alan K. Burnett, M.D. As Therapeutic Area Lead, Myeloid Diseases Jan 12 2015
    CTI BioPharma Appoints Alan K. Burnett, M.D. As Therapeutic Area Lead, Myeloid Diseases Jan 12 2015
    CTI BIOPHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers Jan 09 2015
    CTI BioPharma Announces 2015 Outlook and Recent Drug Portfolio Progress Jan 08 2015
    CTI BioPharma Announces 2015 Outlook and Recent Drug Portfolio Progress Jan 08 2015
    Ahead of the Bell: BrainStorm Cell Therapeutics shares slide Jan 05 2015
    Ahead of the Bell: BrainStorm Cell Therapeutics shares slide Jan 05 2015
    Israel's BrainStorm says stem cell drug benefits most patients in ALS trial Jan 05 2015
    19 Lesser-Known Biotech Stocks With Robust Drug Pipelines Dec 31 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK